EcoDrugPlus

Ensembl ID : ENSPPRG00000023188
Gene Symbol: -
Cross references: -
172 Possible Orthologues:

Ensembl ID : ENSPPRG00000008993
Gene Symbol: -
Cross references: -
165 Possible Orthologues:

Ensembl ID : ENSPPRG00000002251
Gene Symbol: -
Cross references: -
107 Possible Orthologues:

Ensembl ID : ENSPPRG00000002150
Gene Symbol: -
Cross references: -
164 Possible Orthologues:

Ensembl ID : ENSPPRG00000003277
Gene Symbol: -
Cross references: -
147 Possible Orthologues:

Ensembl ID : ENSPPRG00000015500
Gene Symbol: -
Cross references: -
112 Possible Orthologues:

Ensembl ID : ENSPPRG00000016776
Gene Symbol: -
Cross references: -
112 Possible Orthologues:

Ensembl ID : ENSPPRG00000021840
Gene Symbol: -
Cross references: -
124 Possible Orthologues:

Ensembl ID : ENSPPRG00000021681
Gene Symbol: -
Cross references: -
135 Possible Orthologues:

Ensembl ID : ENSPPRG00000012375
Gene Symbol: -
Cross references: -
135 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).